← All news
Markets
Why Is AstraZeneca (LSE:AZN) Advancing Tezspire?
Highlights Tezspire delivered positive results in an inflammatory disease study. The therapy improved inflammation and swallowing-related symptoms. Trial findings are expected to support future regulatory discussions. AstraZeneca and Amgen…
Covered by 1 outlet
All coverage · 1 article